Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties.
Using immunohistochemical methods we determined the presence of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with femoral neck fracture (controls, group 1), painful osteoarthritis (group 2), and painless failed total hip arthroplasties (group 3). Immunoreactive nerve fibers were found in the soft tissue of the fossa acetabuli as well as in the subintimal part of the synovial layer in the hip joint capsule of groups 1 and 2. In the capsule of controls the innervation density had a median of 5.7fibers/cm(2) for CGRP-ir and 3.2fibers/cm(2) for SP-ir afferents. In the osteoarthritic group, the density significantly increased to a median of 15.6fibers/cm(2) for CGRP-ir and 8.2fibers/cm(2) for SP-ir neurons (p=0.05). Patients with failed hip arthroplasties completely lacked these neuropeptide containing afferents. Innervation density in the fossa acetabuli of osteoarthritc patients showed a median of 14.1fibers/cm(2) for CGRP-ir and 5.9fibers/cm(2) for SP-ir afferents. From these data we assume that the hip joint capsule and the soft tissue of the fossa acetabuli are important triggers of nociception. This is supported by the fact, that patients with loosened total hip arthroplasties, where we failed to detect SP- and CGRP-immunoreactive fibers, did not feel pain. The upregulation of SP- and CGRP-positive neurons in response to arthritic stages suggests a mechanism involving neuropeptides in the maintenance of a painful degenerative joint disease and in mediating noxious stimuli from the periphery. Furthermore, these findings help to explain clinical observations, such as effectiveness of local therapy to control hip pain with intraarticular injection, synovectomy and denervation procedures.
Saxler
Guido
G
Department of Orthopaedic Surgery, University of Duisburg - Essen, Hufelandstrasse 55, D-45122 Essen, Germany. guido.saxler@uni-essen.de
Löer
Franz
F
Skumavc
Marc
M
Pförtner
Jörg
J
Hanesch
Ulrike
U
D000368:Aged; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D005260:Female; D006621:Hip Joint / Q000294:innervation* / Q000503:physiopathology*; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009479:Neuropeptides / Q000378:metabolism*; D009619:Nociceptors / Q000166:cytology / Q000378:metabolism*; D015207:Osteoarthritis, Hip / Q000378:metabolism / Q000503:physiopathology*; D010146:Pain / Q000209:etiology / Q000503:physiopathology; D010148:Intractable Pain / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D011183:Postoperative Complications / Q000503:physiopathology; D011984:Sensory Receptor Cells / Q000166:cytology / Q000378:metabolism*; D013373:Substance P / Q000378:metabolism; D013583:Synovial Membrane / Q000294:innervation / Q000503:physiopathology; D015854:Up-Regulation / Q000502:physiology
D009479:Neuropeptides; D013373:Substance P; D015740:Calcitonin Gene-Related Peptide